opacin and opacin-neo trial updates
Published 4 years ago • 138 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
1:39
opacin and opacin-neo: neoadjuvant immunotherapy for advanced melanoma
-
1:16
neoadjuvant ipi nivo in stage iii melanoma: updates from opacin & opacin-neo
-
2:52
opacin-neo trial rfs and biomarker analyses: optimal neoadjuvant ipi/nivo dosing in melanoma
-
1:54
opacin-neo and prado: personalized neoadjuvant io for melanoma based on pathologic response
-
0:57
circulating immune cell subsets in patients with melanoma from the opacin-neo trial
-
2:33
opacin-neo & prado 3-year results in stage iii melanoma: personalized neoadjuvant io benefits
-
1:48
dr. blank on the opacin, opacin-neo trials in stage iii macroscopic melanoma
-
2:53
opacin-neo: tmb and ifn-γ identified as biomarkers of pathologic response in melanoma
-
43:20
case presentation - unilateral abaxial proptosis
-
6:14
neoadjuvant ipilimumab plus nivolumab improves outcomes in resectable advanced melanoma
-
5:11
first-of-its-kind advanced melanoma treatment
-
1:30
omission of adjuvant therapy and tlnd in melanoma: insights from opacin-neo, prado, and nadina
-
1:12
investigators present updated results of the opacin trial for melanoma
-
2:12
omitting total lymph node dissection and adjuvant therapy in melanoma
-
2:43
clinical & tumor characteristics of patients with recurrent melanoma upon immunotherapy
-
2:05
neoadjuvant nivolumab in resectable lung cancer | nejm
-
2:24
prado: personalized response-driven therapy in resectable stage iii melanoma
-
0:37
swog s1801: pathologic response in neoadjuvant-adjuvant vs. adjuvant pembro for resectable melanoma
-
4:09
neoprobe® melanoma procedure animation
-
1:36
nadina trial: neoadjuvant ipilimumab nivolumab vs. adjuvant nivolumab in stage iii melanoma
-
0:37
tils prolong pfs compared with pembrolizumab in advanced melanoma
-
2:15
dr hauschild on the role of adjuvant/neoadjuvant therapy in melanoma management